Login with your work email address to view charts. No credit card required.
| Art Unit: | 1623 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1620 — Biomedicinal Chemistry |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 514 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 568 — Organic compounds -- part of the class 532-570 series 426 — Food or edible material: processes, compositions, and products 128 — Surgery 117 — Single-crystal, oriented-crystal, and epitaxy growth processes; non-coating apparatus therefor |
| Phone: | Available with subscription |
| Email: | Available with subscription |
| Title: | Supervisory Patent Examiner |
| Service: | 18 years |
| Grade: | GS-15 |
| 3-Year Grant rate: | 15% over 141 cases |
|---|---|
| Difficulty: | Extremely Hard |
| Difficulty Percentile: | 94th
|
With Examiner Milligan (SPE), you have a 15% chance of getting an issued patent by 3 years after the first office action. Examiner Milligan (SPE) is an extremely hard examiner and in the 94th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Milligan (SPE), where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Milligan (SPE)'s grant rate is lower than that of Art Unit 1623 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Milligan (SPE) | 3.8 |
| Art Unit 1623 | 1.5 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.